Copyright 2009 Medical News Today Latest Breast Cancer News From Medical News Today. http://www.medicalnewstoday.com/sections/breast_cancer/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Sat, 04 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156371.php http://www.medicalnewstoday.com/articles/156371.php A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. Researchers successfully used PET and a specially-developed radioactive compound to image HER2 - a protein often associated with aggressive breast cancer - in breast cancer cells before and after treatment aimed at decreasing HER2 expression. Breast Cancer Fri, 03 Jul 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/156331.php http://www.medicalnewstoday.com/articles/156331.php The Patients Doctors Don't Know The New York Times All medical students are required to have clinical experiences in pediatrics and obstetrics, even though after they graduate most will never treat a child or deliver a baby. Medical Students / Training Fri, 03 Jul 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/156337.php http://www.medicalnewstoday.com/articles/156337.php Women with breast cancer who receive chemotherapy appear more likely than those treated with radiation therapy to experience a major change in work status, according to a study published in the journal Cancer, Reuters reports. For the study, Breast Cancer Fri, 03 Jul 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/156239.php http://www.medicalnewstoday.com/articles/156239.php The single-nucleotide polymorphism (SNP) known as 2q35-rs13387042 is associated with increased risk of estrogen receptor (ER) -positive and -negative breast cancer, according to a study published online July 1 in the Journal of the National Cancer Institute. This study was undertaken to confirm previous research that identified this SNP as a marker of susceptibility to ER-positive breast cancer. Roger L. Milne, Ph.D. Breast Cancer Fri, 03 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156220.php http://www.medicalnewstoday.com/articles/156220.php New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. The study is published in the July edition of the journal Molecular Endocrinology. Breast Cancer Thu, 02 Jul 2009 07:00:00 PDT http://www.medicalnewstoday.com/articles/156202.php http://www.medicalnewstoday.com/articles/156202.php Some patients who suffer from recurrent cancer at the chest wall now have another option. The Radiation Oncology Department at Saint Barnabas Medical Center is one of a few hospitals nationwide to participate in a study which combines the use of the heat-sensitive chemotherapeutic agent ThermoDox® with microwave hyperthermia, or heat. Depending on risk factors, a large percentage of women with mastectomies may experience recurrent chest wall (RCW) breast cancer. Breast Cancer Wed, 01 Jul 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/155954.php http://www.medicalnewstoday.com/articles/155954.php Abraxis BioScience, Inc. (NASDAQ:ABII), an integrated biotechnology company, announced the listing of ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) 100 mg in Quebec for the treatment of metastatic breast cancer with a recommendation from the Quebec Conseil du Médicament and approval from the Quebec Ministry of Health. Breast Cancer Wed, 01 Jul 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/155955.php http://www.medicalnewstoday.com/articles/155955.php BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), which is developing a testosterone gel (LibiGel®) to treat hypoactive sexual desire disorder (HSDD) in women, is pleased to comment on results in a paper published in the July issue of The Journal of Sexual Medicine showing testosterone has no effect on the incidence of invasive breast cancer among menopausal women who use testosterone to improve sexual function. The study, led by Susan Davis, M.D. Sexual Health / STDs Wed, 01 Jul 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/155928.php http://www.medicalnewstoday.com/articles/155928.php Physiological changes associated with the metabolic syndrome may play a role in the risk of postmenopausal breast cancer, according to study results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Breast Cancer Wed, 01 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155874.php http://www.medicalnewstoday.com/articles/155874.php XCounter AB (publ) (AIM:XCT), a technology leader in the development of tomosynthesis-based 3D medical imaging, announced positive initial results from the first clinical evaluation of its innovative breast screening device XC Mammo - 3T. The device is the world's first dedicated 3D digital mammography system for the detection of breast cancer, the most common form of cancer found in women. Breast Cancer Tue, 30 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/155753.php http://www.medicalnewstoday.com/articles/155753.php A University of Wisconsin-Madison biomedical engineer and colleagues have developed a method that, applied in MRI scans of the breast, could spare some women with increased breast cancer risk the pain and stress of having to endure a biopsy of a questionable lump or lesion. The universal technology will give radiologists greater confidence in visually classifying a lesion as malignant or benign. Breast Cancer Tue, 30 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155717.php http://www.medicalnewstoday.com/articles/155717.php A groundbreaking non-invasive breast cancer treatment will be unveiled at this year's Royal Society Summer Science Exhibition . Scientists led by world-renowned breast cancer expert, Mr Mo Keshtgar, are the first to use photodynamic therapy (PDT) to treat what is now the most common cancer in the UK. Breast Cancer Mon, 29 Jun 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/155704.php http://www.medicalnewstoday.com/articles/155704.php A new analysis of the incidence of breast cancer in Italy per 100,000 women between the ages of 0 to 84 from 2000 to 2005 shows a 72 percent spike above official estimates issued by the Ministry of Health, with the sharpest uptick of +28.6 percent found in the youngest group studied (ages 25 to 44). Breast Cancer Sun, 28 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155542.php http://www.medicalnewstoday.com/articles/155542.php The recent decline in invasive breast cancer in the US was significantly less pronounced in the poor and those who live in rural areas. Researchers writing in the open access journal BMC Medicine suggest this may be due to varying reductions in the numbers of women taking hormone therapy (HT). Christina Clarke, Ph.D. Breast Cancer Sat, 27 Jun 2009 08:00:00 PDT http://www.medicalnewstoday.com/articles/155599.php http://www.medicalnewstoday.com/articles/155599.php UroToday.com - Prostate and breast cancer appear to be homologous cancer in males and females respectively. Both cancers share hormone etiologies and are treated with hormonal manipulation. The incidence of these two hormone-dependent cancers has steadily risen throughout the twentieth century. Prostate / Prostate Cancer Fri, 26 Jun 2009 07:00:00 PDT http://www.medicalnewstoday.com/articles/155525.php http://www.medicalnewstoday.com/articles/155525.php The drug, called olaparib, specifically targets hereditary cancer caused by faulty BRCA1 and BRCA2 genes. The small scale patient trial has shown remarkable benefit for patients with breast, ovarian and prostate cancer. The trial was carried out by The Institute of Cancer Research with the Royal Marsden Hospital, working with pharmaceutical company AstraZeneca, with results published in the New England Journal of Medicine on 9 July 2009. Breast Cancer Fri, 26 Jun 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/155507.php http://www.medicalnewstoday.com/articles/155507.php Reviewing the records of 577 breast cancer patients, Fox Chase Cancer Center researchers found that women with newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment. The study demonstrates that, despite the lack of evidence of their benefit, routine use of MRI scans in women newly diagnosed with breast cancer increased significantly between 2004 and 2005, and again in 2006. Breast Cancer Fri, 26 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/155429.php http://www.medicalnewstoday.com/articles/155429.php Retinoic acid, a derivative of vitamin A, could lead researchers to a new set of drug targets for treating breast cancer, researchers from the University of Chicago report in the June 25, 2009, issue of the journal Cell. The most common forms of breast cancer are fueled by the female hormone estrogen. By comparing the effects of estrogen and retinoic acid on the entire genome, the researchers found that they have a "yin-yang" effect. Breast Cancer Fri, 26 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/155433.php http://www.medicalnewstoday.com/articles/155433.php If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. However, breast cancer is rare in adolescents, and the vast majority of teenage breast lumps turn out to be benign masses that are related to hormones. A recent Loyola University Health System study published in the American Journal of Roentgenology suggests that a breast ultrasound examination might eliminate the need for biopsy in many cases. Breast Cancer Fri, 26 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155385.php http://www.medicalnewstoday.com/articles/155385.php Dr. Arne Ostman and colleagues at the Karolinska Institutet in Stockholm have identified a stromal marker for breast cancer progression. They present these findings in the July 2009 issue of the American Journal of Pathology. Platelet-derived growth factor (PDGF) receptors are involved in multiple stages of cancer cell growth. However, the contribution of PDGFR expression in the stroma, or surrounding supportive tissue, of the tumor remains unclear. Breast Cancer Thu, 25 Jun 2009 07:00:00 PDT http://www.medicalnewstoday.com/articles/155371.php http://www.medicalnewstoday.com/articles/155371.php Apthera, Inc. announced that it reached an agreement with the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for its planned Phase III clinical trial of the Company's lead drug, NeuVax. The SPA is a written agreement between the trial's sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of the Phase III trial to be used in support of a Biologics License Application (BLA). Breast Cancer Thu, 25 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/155294.php http://www.medicalnewstoday.com/articles/155294.php Scientists at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital, working with pharmaceutical company AstraZeneca, have completed a Phase I clinical trial demonstrating the great promise of a completely new type of cancer treatment. The results are announced today in The New England Journal of Medicine. Breast Cancer Thu, 25 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155218.php http://www.medicalnewstoday.com/articles/155218.php Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling. Breast Cancer Thu, 25 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155283.php http://www.medicalnewstoday.com/articles/155283.php Scientists in the US have discovered that cancer tumors that don't spread to other parts of the body secrete a protein called prosaposin and that metastatic tumors, which do spread, don't secrete much of it. They suggest this discovery could lead the way to developing new treatments that stop cancers from spreading. The research was the work of a team at Children's Hospital Boston, Massachusetts, led by Dr Randoph S. Cancer / Oncology Wed, 24 Jun 2009 10:00:00 PDT http://www.medicalnewstoday.com/articles/155232.php http://www.medicalnewstoday.com/articles/155232.php A US doctor who diagnosed and treated herself for breast cancer while stationed in the South Pole during the winter of 1999, was then rescued and survived, has died. Dr Jerri Nielsen FitzGerald, aged 57 and a native of Ohio, died at her home in Southwick, Massachusetts, on Tuesday her husband Thomas FitzGerald told the press. Nielsen's cancer came back in 2005, this time in her brain, said a CBS3 report. Breast Cancer